 |
 |
 |
Search Issue:
Indrayani Biotech Rights Issue 2026 Details, Price, Date, TimeTable and Review
Indrayani Biotech is coming up with a Rights Issue. The company plans to raise up to ₹48.79 crore by issuing 3,25,25,897 equity shares. The issue price is set at ₹15 per share (face value of ₹10 per share), which includes a premium of ₹5 per share. Eligible shareholders will be entitled to 5 : 7. The record date to determine eligibility is Apr 28, 2026. As per the terms of payment, ₹3.75 per share payable on application, with the balance payable in call(s).. MUFG Intime India Private Limited is the Registrar to the Issue.
For detailed information, investors are advised to refer to the Indrayani Biotech Rights Issue Letter of Offer .
For detailed information, investors are advised to refer to the Indrayani Biotech Rights Issue Letter of Offer .
Indrayani Biotech Share Price Analysis API (Live)
▼
₹7.68
-0.13 (-1.66%)
As of 01 Sep, 2026
Open
₹7.81
Day High - Low
₹7.84 - ₹7.40
Volume
31,263
52 Weeks High
₹16.47
on 06 Nov 2025
52 Weeks Low
₹6.10
on 19 Mar 2026
RSI (14)
45.8
50 DMA
8.07
200 DMA
10.09
Loading...
Objects of the Issue
| S.No | Object | Amount (in ₹, Cr) |
|---|---|---|
| 1 | To part finance working capital requirement of the company. | 20.65 |
| 2 | Set off amount from the outstanding loan given by the promoter to the company, at the rights issue price. | 5.00 |
| 3 | Set off amount from the outstanding unsecured advance received from Bougainvillea Investments Private Limited (BIPL) by allotting equity shares, at the rights issue price, against rights entitlement and any additional rights entitlement acquired. | 12.75 |
| 4 | To meet General corporate purposes | 11.48 |
Indrayani Biotech Financials (Restated Consolidated)
Annual Performance (31 Mar 24 vs 31 Mar 23)
Indrayani Biotech Financials (Restated Consolidated)'s Assets increased by 50.7%, Revenue increased by 0%, Profit After Tax dropped by 12.7% compared to the previous financial year.
Assets
▲ 50.7%
(79.07)
Revenue
▲ 0%
(0.03)
Profit After Tax
▼ 12.7%
(-1.51)
| 31 Mar 24 In Cr. | 31 Mar 23 In Cr. | |
|---|---|---|
| Assets | 235.03 | 155.96 |
| Revenue | 167.44 | 167.41 |
| Profit After Tax | 10.42 | 11.93 |
About Indrayani Biotech
Incorporated on 9 March 1992 and headquartered in Chennai, Tamil Nadu, Indrayani Biotech Limited is a diversified Indian conglomerate that uniquely operates through an aggregation model of acquiring and partnering with established small and medium sized businesses across India. The company operates in seven major business segments (Food & Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure) with each professionally managed by an independent expert team.
Indrayani Biotech Limited supports MSMEs with high potential, helping them grow vertically and achieve inclusive growth by building a strong ecosystem where businesses support each other.